Denmark · Delayed Price · Currency is DKK BioMar Group Statistics
Total Valuation
BioMar Group has a market cap or net worth of DKK 13.47 billion. The enterprise value is 16.65 billion.
| Market Cap | 13.47B |
| Enterprise Value | 16.65B |
Important Dates
The next confirmed earnings date is Tuesday, November 3, 2026.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioMar Group has 100.23 million shares outstanding. The number of shares has increased by 0.02% in one year.
| Current Share Class | 100.23M |
| Shares Outstanding | 100.23M |
| Shares Change (YoY) | +0.02% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 12.53% |
| Float | 25.96M |
Valuation Ratios
The trailing PE ratio is 19.04 and the forward PE ratio is 13.55. BioMar Group's PEG ratio is 0.87.
| PE Ratio | 19.04 |
| Forward PE | 13.55 |
| PS Ratio | 0.81 |
| PB Ratio | 4.82 |
| P/TBV Ratio | 9.11 |
| P/FCF Ratio | 11.33 |
| P/OCF Ratio | 8.89 |
| PEG Ratio | 0.87 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.55, with an EV/FCF ratio of 14.00.
| EV / Earnings | 23.58 |
| EV / Sales | 1.00 |
| EV / EBITDA | 8.55 |
| EV / EBIT | 14.32 |
| EV / FCF | 14.00 |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 1.34.
| Current Ratio | 1.07 |
| Quick Ratio | 0.65 |
| Debt / Equity | 1.34 |
| Debt / EBITDA | 1.98 |
| Debt / FCF | 3.14 |
| Interest Coverage | 5.62 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 13.32% |
| Return on Capital Employed (ROCE) | 21.93% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 9.25M |
| Profits Per Employee | 390,487 |
| Employee Count | 1,808 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioMar Group has paid 268.00 million in taxes.
| Income Tax | 268.00M |
| Effective Tax Rate | 26.75% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 114.04 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 77.64 |
| Average Volume (20 Days) | 134,807 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioMar Group had revenue of DKK 16.73 billion and earned 706.00 million in profits. Earnings per share was 7.06.
| Revenue | 16.73B |
| Gross Profit | 3.73B |
| Operating Income | 1.11B |
| Pretax Income | 1.00B |
| Net Income | 706.00M |
| EBITDA | 1.74B |
| EBIT | 1.11B |
| Earnings Per Share (EPS) | 7.06 |
Balance Sheet
The company has 563.00 million in cash and 3.74 billion in debt, with a net cash position of -3.18 billion or -31.68 per share.
| Cash & Cash Equivalents | 563.00M |
| Total Debt | 3.74B |
| Net Cash | -3.18B |
| Net Cash Per Share | -31.68 |
| Equity (Book Value) | 2.79B |
| Book Value Per Share | 27.88 |
| Working Capital | 428.00M |
Cash Flow
In the last 12 months, operating cash flow was 1.52 billion and capital expenditures -326.00 million, giving a free cash flow of 1.19 billion.
| Operating Cash Flow | 1.52B |
| Capital Expenditures | -326.00M |
| Depreciation & Amortization | 635.00M |
| Net Borrowing | -709.00M |
| Free Cash Flow | 1.19B |
| FCF Per Share | 11.86 |
Margins
Gross margin is 22.33%, with operating and profit margins of 6.61% and 4.22%.
| Gross Margin | 22.33% |
| Operating Margin | 6.61% |
| Pretax Margin | 5.99% |
| Profit Margin | 4.22% |
| EBITDA Margin | 10.41% |
| EBIT Margin | 6.61% |
| FCF Margin | 7.11% |
Dividends & Yields
BioMar Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 1.42% |
| Buyback Yield | -0.02% |
| Shareholder Yield | -0.02% |
| Earnings Yield | 5.24% |
| FCF Yield | 8.83% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BioMar Group is 138.80, which is 3.97% higher than the current price. The consensus rating is "Buy".
| Price Target | 138.80 |
| Price Target Difference | 3.97% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 5.36% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioMar Group has an Altman Z-Score of 2.95 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.95 |
| Piotroski F-Score | 5 |